A genetic marker for rheumatic heart disease

C N Rajapakse1, K Halim, I Al-Orainey

  • 1Department Medicine, King Saud University, Riyadh, Saudi Arabia.

British Heart Journal
|December 1, 1987
PubMed

Insights

The human leukocyte antigen DR4 (HLA-DR4) is significantly more common in patients with rheumatic heart disease and acute rheumatic fever. This finding suggests a potential link between HLA-DR4 and the development of these conditions.

Area of Science:

  • Immunogenetics
  • Rheumatology
  • Cardiovascular Disease

Background:

  • Rheumatic heart disease (RHD) and acute rheumatic fever (ARF) are significant global health concerns.
  • The genetic factors influencing susceptibility to RHD and ARF are not fully understood.
  • Previous studies have suggested a potential role for human leukocyte antigen (HLA) genes.

Purpose of the Study:

  • To investigate the frequency of specific HLA antigen types (A, B, C, and DR) in Saudi patients with RHD and ARF.
  • To compare HLA antigen frequencies between patients and healthy controls.
  • To explore the association between HLA-DR4 and the severity of valvular heart disease in RHD patients.

Main Methods:

  • A case-control study comparing HLA antigen frequencies.
  • Unselected groups of 25 patients with chronic RHD, 15 patients with ARF, and 100 healthy Arab volunteers of Saudi origin.
  • HLA typing for antigens A, B, C, and DR.
  • Analysis of HLA-DR4 frequency in relation to valvular lesions (mitral stenosis, aortic incompetence).

Main Results:

  • A significantly higher frequency of HLA-DR4 was observed in both RHD (72%) and ARF (53%) patient groups compared to healthy controls (12%).
  • The combined patient groups showed a 65% frequency of HLA-DR4, with a high relative risk (13.6).
  • HLA-DR4 was prevalent in RHD patients with mitral stenosis (83%) and aortic incompetence (70%).
  • Similar HLA-DR4 frequencies were found in non-Saudi Arab patients with RHD or ARF.

Conclusions:

  • The study identifies a strong association between HLA-DR4 and susceptibility to ARF and RHD in the studied population.
  • HLA-DR4 may play a role in the pathogenesis of rheumatic fever and subsequent heart disease.
  • These findings warrant further investigation into the immunogenetic mechanisms underlying rheumatic fever and RHD.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...